drugset / Trial / NCT03860688

Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins

NCT03860688

Phase 2/3 Unknown 15 enrolled University Health Network, Toronto
NaSingle-groupOpen-labelBasic science

Summary

Some of the fat (triglyceride) from the food humans eat gets stored in the bowel. This triglyceride can then be released into the blood when another meal is consumed or in response to hormones. How the gut hormone glucagon-like peptide-2 (GLP-2) and glucose release the triglyceride from the gut is not known. The research team in this study is interested in finding out how teduglutide (a degradation resistant form of GLP-2) ang glucose, given together, release stored triglyceride from the gut by evaluating how blood lipoproteins respond to teduglutide in healthy individuals.

Timeline

Start
2019-05-01
Primary completion
2021-12-01
Completion
2022-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Teduglutide Peptide 0.05 mg/kg Subcutaneous
Background Glucose Unknown 25 g Oral

Indications